← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-12 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
ADCBiologicstaleAstraZenecaPhase 1

[225Ac]-FPI-2068 ([225Ac]-FPI-2068)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleVanderbilt-Ingram Cancer CenterPhase 1

[68Ga]Ga-ABY-025 ([68Ga]Ga-ABY-025)

Locally Advanced Cancer; Metastatic Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleM.D. Anderson Cancer CenterPhase 2

^111 In Ibritumomab Tiuxetan (^111 In Ibritumomab Tiuxetan)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 0.8%임상시험 1상태 DISCONTINUED
AntibodystaleUniversity Hospital, Strasbourg…Approved

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleChildren's Hospital of Fudan Un…Phase 1

alloCART-19 (alloCART-19)

ALL, Childhood B-Cell · ALL, Childhood B-Cell

#ALLChildhoodB-Cell#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing 302 HospitalPhase 2

allogeneic NK cells therapy (allogeneic NK cells therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleChengdu Ucello Biotechnology Co…Phase 1

allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA (allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA)

SLE - Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 1

an antibody drug conjugate (an antibody drug conjugate)

Neoplasms · Neoplasms

#Neoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 31.2%임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

anti TNFa monoclonal antibody - Infliximab (anti TNFa monoclonal antibody - Infliximab)

Endometriosis · Endometriosis

#Endometriosis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleThe Children's Hospital of Zhej…Phase 1

anti-BCMA/CD70-CAR-T cells (anti-BCMA/CD70-CAR-T cells)

CAR T Cell Therapy; Systemic Lupus Erythematosus · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChangzhou No.2 People's HospitalPhase 1

KN5501 (anti-CD19 CAR NK cells, anti-CD19 CAR NK cells (KN5501))

Thrombocytopenia Alloimmune · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 1상태 RECRUITING
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

anti-CD19 IL10/IL15 CAR-NK (anti-CD19 IL10/IL15 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

anti-CD19 and anti-BCMA CAR (anti-CD19 and anti-BCMA CAR)

Safety and Efficacy · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleNational University Health Syst…Phase 1

anti-CD19 redirected NK cells (anti-CD19 redirected NK cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleShanghai First Song Biotechnolo…Phase 1

anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells (anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells)

Relapsed/refractory Lymphoma; Relapsed/Refractory Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

anti-CD19/22-CAR vector-transduced T cells (anti-CD19/22-CAR vector-transduced T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleGracell Biotechnologies (Shangh…Preclinical

CHT105 (anti-CD19/70 CAR T cells, anti-CD19/70 CAR T cells (CHT105))

Systemic Lupus Erythematosus; Lupus Nephritis · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleJieyang People's HospitalPhase 1

anti-CD19/BCMA CAR NK cells (anti-CD19/BCMA CAR NK cells)

IgA Nephropathy (IgAN) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThe Children's Hospital of Zhej…Phase 1

KN5601 (anti-CD19/BCMA CAR NK cells, anti-CD19/BCMA CAR NK cells (KN5601))

Autoimmune Diseases; Systemic Lupus Erthematosus · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstalePeng LiuPhase 1

anti-CD19/BCMA CAR-T cells (anti-CD19/BCMA CAR-T cells)

Multiple Myeloma in Relapse; Multiple Myeloma Progression · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE

165 / 177 페이지

← 이전다음 →